MitoRx Therapeutics Announced Seed Funding To Advance Mitochondrial Protective Therapeutics To Treat Degenerative Diseases

MitoRx Therapeutics (MitoRx), a biotechnology company has been developing novel therapeutics that is reversing the mitochondrial dysfunction for the purpose of arresting the progression of the degenerative diseases and the company has announced the close if its seed financing and the financial details have not been disclosed. The company has also announced the appointment of […]

Continue Reading